CAS No.
[84611-23-4(Unlabelled)]
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
2-[(2-Oxothiolan-3-yl)carbamoylmethylsulfanyl]acetic acid-13C4
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Erdosteine-13C4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Erdosteine-13C4 usage and description
Erdosteine 13C4 is a stable isotope-labeled version of the drug Erdosteine, which is used for the treatment of chronic obstructive pulmonary disease (COPD), bronchitis, and other respiratory disorders. The drug is classified as a mucolytic agent, which means that it helps to break down mucus that accumulates in the airways, making it easier to cough up and clear from the lungs.
Erdosteine 13C4 works by stimulating the production of natural enzymes in the body that break down mucus, as well as by reducing inflammation and oxidative stress in the airways. It has also been shown to have antioxidant properties, which may help to protect the lungs from damage caused by free radicals.
The chemical structure of Erdosteine 13C4 is similar to that of the non-labeled drug, but it contains four carbon-13 isotopes, which can be used in research studies to track the metabolism and distribution of the drug in the body. The labeled drug can also be used in clinical trials to determine the bioavailability and pharmacokinetics of the drug after administration.
Overall, Erdosteine 13C4 is a valuable tool for researchers studying the mechanisms of action and potential therapeutic benefits of Erdosteine for respiratory diseases.
